These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1152 related articles for article (PubMed ID: 36414625)

  • 21. Cuproptosis in lung cancer: therapeutic options and prognostic models.
    Jawed R; Bhatti H
    Apoptosis; 2024 Oct; 29(9-10):1393-1398. PubMed ID: 38735011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
    Yuan HJ; Xue YT; Liu Y
    Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cuproptosis is involved in copper-induced hepatotoxicity in chickens.
    Zhong G; Li L; Li Y; Ma F; Liao J; Li Y; Zhang H; Pan J; Hu L; Tang Z
    Sci Total Environ; 2023 Mar; 866():161458. PubMed ID: 36621474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cuproptosis: Mechanism, role, and advances in urological malignancies.
    Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
    Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SP1/CTR1-mediated oxidative stress-induced cuproptosis in intervertebral disc degeneration.
    Chen X; Li K; Xiao Y; Wu W; Lin H; Qing X; Tian S; Liu S; Feng S; Wang B; Shao Z; Peng Y
    Biofactors; 2024 Apr; ():. PubMed ID: 38599595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives.
    Zhang C; Huang T; Li L
    J Hematol Oncol; 2024 Aug; 17(1):68. PubMed ID: 39152464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copper homeostasis and cuproptosis in atherosclerosis: metabolism, mechanisms and potential therapeutic strategies.
    Yang S; Li Y; Zhou L; Wang X; Liu L; Wu M
    Cell Death Discov; 2024 Jan; 10(1):25. PubMed ID: 38218941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Cross-Communication of Cuproptosis and Regulated Cell Death in Human Pathophysiology.
    Tsui KH; Hsiao JH; Lin LT; Tsang YL; Shao AN; Kuo CH; Chang R; Wen ZH; Li CJ
    Int J Biol Sci; 2024; 20(1):218-230. PubMed ID: 38164173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
    Han J; Luo J; Wang C; Kapilevich L; Zhang XA
    Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Research progress in cuproptosis in liver cancer.
    Chen L; Liu D; Tan Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1368-1376. PubMed ID: 38044648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?
    Zhao R; Sukocheva O; Tse E; Neganova M; Aleksandrova Y; Zheng Y; Gu H; Zhao D; Madhunapantula SV; Zhu X; Liu J; Fan R
    Cell Commun Signal; 2024 Jul; 22(1):379. PubMed ID: 39068453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics.
    Yang L; Yang P; Lip GYH; Ren J
    Trends Pharmacol Sci; 2023 Sep; 44(9):573-585. PubMed ID: 37500296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulated Wnt/β-catenin signaling confers resistance to cuproptosis in cancer cells.
    Liu YT; Chen L; Li SJ; Wang WY; Wang YY; Yang QC; Song A; Zhang MJ; Mo WT; Li H; Hu CY; Sun ZJ
    Cell Death Differ; 2024 Jul; ():. PubMed ID: 38987382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cuproptosis: potential new direction in diabetes research and treatment.
    Qu J; Wang Y; Wang Q
    Front Endocrinol (Lausanne); 2024; 15():1344729. PubMed ID: 38904034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cuproptosis: mechanisms and links with cancers.
    Xie J; Yang Y; Gao Y; He J
    Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The implications and prospect of cuproptosis-related genes and copper transporters in cancer progression.
    Zhao Q; Qi T
    Front Oncol; 2023; 13():1117164. PubMed ID: 36925927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death.
    Gu J; Guo C; Ruan J; Li K; Zhou Y; Gong X; Shi H
    Apoptosis; 2024 Jun; 29(5-6):586-604. PubMed ID: 38324163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory roles of copper metabolism and cuproptosis in human cancers.
    Wang Z; Jin D; Zhou S; Dong N; Ji Y; An P; Wang J; Luo Y; Luo J
    Front Oncol; 2023; 13():1123420. PubMed ID: 37035162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer.
    Wang W; Lu K; Jiang X; Wei Q; Zhu L; Wang X; Jin H; Feng L
    J Exp Clin Cancer Res; 2023 Jun; 42(1):142. PubMed ID: 37277863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copper neurotoxicity: Induction of cognitive dysfunction: A review.
    Feng D; Zhao Y; Li W; Li X; Wan J; Wang F
    Medicine (Baltimore); 2023 Dec; 102(48):e36375. PubMed ID: 38050287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.